合作客戶/
拜耳公司 |
同濟(jì)大學(xué) |
聯(lián)合大學(xué) |
美國(guó)保潔 |
美國(guó)強(qiáng)生 |
瑞士羅氏 |
相關(guān)新聞Info
-
> 應(yīng)用熒光顯微鏡研究了蛋白質(zhì)在氣-水界面的組裝——摘要、介紹
> 篩選常用、經(jīng)濟(jì)且可抑制低階煤煤塵的表面活性劑(一)
> 誘導(dǎo)期測(cè)定法研究NaCl的添加對(duì)碳酸鋰固-液界面張力等成核動(dòng)力學(xué)參數(shù)影響——過飽和度的計(jì)算
> 低界面張力納米流體提高低滲透油藏壓裂滲吸速率和采收率(一)
> 拉筒法和靜滴法測(cè)定連鑄結(jié)晶器保護(hù)渣表面張力(一)
> 水面上單分子層膜通過磷脂光控開關(guān)實(shí)現(xiàn)可逆光學(xué)控制——結(jié)論、致謝!
> 表面活性劑對(duì)煤塵潤(rùn)濕效果的定量化研究
> 毛細(xì)現(xiàn)象:表面張力和接觸角兩者有什么關(guān)系?
> 探究LB復(fù)合膜的酸致變色特性
> 鋰電池隔膜粘接劑組合物稀釋液表面張力測(cè)試及影響
推薦新聞Info
-
> 釕催化劑合成丁炔二醇醚三硅氧烷表面活性劑反應(yīng)條件及表面張力測(cè)定(三)
> 釕催化劑合成丁炔二醇醚三硅氧烷表面活性劑反應(yīng)條件及表面張力測(cè)定(二)
> 釕催化劑合成丁炔二醇醚三硅氧烷表面活性劑反應(yīng)條件及表面張力測(cè)定(一)
> 座滴法測(cè)量玻璃熔體表面張力準(zhǔn)確性及影響因素
> 座滴法測(cè)量玻璃熔體表面張力裝置、步驟
> 液體表面張力受力分析圖:原理、數(shù)學(xué)模型、應(yīng)用與實(shí)例
> 各向異性表面張力條件下定向凝固共晶生長(zhǎng)形態(tài)穩(wěn)定性(下)
> 各向異性表面張力條件下定向凝固共晶生長(zhǎng)形態(tài)穩(wěn)定性(上)
> NaOL、HZ組合捕收劑對(duì)鋰輝石礦物浮選效果、表面張力影響(三)
> NaOL、HZ組合捕收劑對(duì)鋰輝石礦物浮選效果、表面張力影響(二)
Delta-8 動(dòng)物胃腸道體內(nèi)中藥物的溶解度的測(cè)定——結(jié)論、工具書類!
來源:上海謂載 瀏覽 1431 次 發(fā)布時(shí)間:2021-11-26
結(jié)論
胃腸道pH值和緩沖容量的種間差異是重要的考慮因素,尤其是對(duì)胃腸道給藥的pHresponsive配方和可電離藥物。 因此,兔子和豬的空腸、回腸和近端結(jié)腸具有相對(duì)較高的緩沖容量,而豬遠(yuǎn)端結(jié)腸具有較低的緩沖容量是非常重要的考慮因素。 與人相比,大鼠、兔和豬的近端小腸和升結(jié)腸的液體的滲透壓和表面張力也較高。 胃腸道特征的這些差異導(dǎo)致潑尼松龍?jiān)诖笫篌w內(nèi)的溶解度較高(近端結(jié)腸除外),而潑尼松龍?jiān)谪i和兔體內(nèi)的溶解度與人類相當(dāng)。 因此,如果在大鼠的體液中測(cè)量,中性化合物潑尼松龍的溶解度可能被高估。 另一方面,可電離藥物美沙拉秦在兔和豬體內(nèi)的溶解度在小腸中部高于人,在結(jié)腸中低于人,僅在小腸遠(yuǎn)端與人相當(dāng)。 胃腸道環(huán)境的差異,如pH值、緩沖容量、滲透壓和表面張力,導(dǎo)致藥物溶解度的差異。 在兔子和豬中,美沙拉秦的溶解度在沿胃腸道向下移動(dòng)時(shí)發(fā)生顯著變化,這在很大程度上受管腔液的pH值和滲透壓的影響。
工具書類
1. Flaisher-Grinberg S et al. Models of mania: from facets to domains and from animal models to model animals. J Psychopharmacol 2010; 24: 437–438.
2. Insel TR. From animal models to model animals. Biol Psychiatry 2007; 62: 1337–1339.
3. Hannah-Poquette C et al. Modeling mania: further validation for Black Swiss mice as model animals. Behav Brain Res 2011; 223: 222–226.
4. Calabrese EJ. Gastrointestinal and dermal absorption – interspecies differences. Drug Metab Rev 1984; 15: 1013–1032.
5. Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory-animals. Biopharm Drug Dispos 1995; 16: 351–380.
6. McConnell EL et al. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments. J Pharm Pharmacol 2008; 60: 63–70.
7. Ward FW, Coates ME. Gastrointestinal pH measurement in rats: influence of the microbial flora, diet and fasting. Lab Anim 1987; 21: 216–222.
8. Smith HW. Observations on the Flora of the alimentary tract of animals and factors affecting its composition. J Pathol Bacteriol 1965; 89: 95–122.
9. Clarysse S et al. Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states. J Pharm Sci 2009; 98: 1177–1192.
10. Kalantzi L et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006; 23: 165–176.
11. Fadda HM et al. Drug solubility in luminal fluids from different regions of the small and large intestine of humans. Mol Pharm 2010; 7: 1527– 1532.
12. Merchant HA et al. Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug development. Eur J Pharm Sci 2011; 42: 3–10.
13. ToxNet. Mesalamine: Toxicology data network (ToxNet). US National Library of Medicine, CASRN: 89-57-6. 2014. (http://toxnet.nlm.nih.gov/cgi-bin/sis/ search2/r?dbs+hsdb:@term+@rn+@ rel+89-57-6, last accessed 25th June 2014).
14. Machatha SG, Yalkowsky SH. Comparison of the octanol/water partition coefficients calculated by ClogP, ACDlogP and KowWin to experimentally determined values. Int J Pharm 2005; 294: 185–192.
15. McConnell EL et al. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 2008; 364: 213–226.
16. Mudie DM et al. Physiological parameters for oral delivery and in vitro testing. Mol Pharm 2010; 7: 1388– 1405.
17. French DL, Mauger JW. Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery. Pharm Res 1993; 10: 1285–1290.
18. Perez de la Cruz Moreno M et al. Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum. J Pharm Pharmacol 2006; 58: 1079–1089. 19. Diakidou A et al. Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults. Pharm Res 2009; 26: 2141–2151.
Delta-8 動(dòng)物胃腸道體內(nèi)中藥物的溶解度的測(cè)定——摘要、介紹
Delta-8 動(dòng)物胃腸道體內(nèi)中藥物的溶解度的測(cè)定——材料和方法